Xencor

Valuation Analysis

About the Company

Xencor en bref

Xencor (XNCR) is currently trading at 11,03 € with a market capitalization of 818 M €. The 52-week range spans from 6,04 € to 16,31 €; the current price is 32.4% below the yearly high. Year-over-year revenue growth stands at -86.2%.

💰 Dividende

Xencor currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

12 analystes évaluent Xencor (XNCR) au consensus : Achat Fort. L'objectif de cours moyen est de 24,87 €, soit un potentiel de +125.47% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 12,22 € à 37,53 €.

Xencor : la thèse d'investissement en détail

Xencor (XNCR) operates in the Healthcare — specifically Biotechnology — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Strong Buy with an average price target implying roughly 125.47% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Revenue is contracting at -86.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 20.88% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The analyst consensus price target implies 125.47% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (20.88%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Xencor?

Compare top-rated brokers — low fees, trusted providers, fully regulated.